Suppr超能文献

老年晚期慢性肾脏病患者透析与保守治疗的基于价值的评估:一项队列研究

Value-based evaluation of dialysis versus conservative care in older patients with advanced chronic kidney disease: a cohort study.

作者信息

Verberne Wouter R, Dijkers Janneke, Kelder Johannes C, Geers Anthonius B M, Jellema Wilbert T, Vincent Hieronymus H, van Delden Johannes J M, Bos Willem Jan W

机构信息

Department of Internal Medicine, St Antonius Hospital, Koekoekslaan 1, 3435 CM, Utrecht, Nieuwegein, The Netherlands.

Department of Clinical Epidemiology and Medical Statistics, St Antonius Hospital, Nieuwegein, Utrecht, The Netherlands.

出版信息

BMC Nephrol. 2018 Aug 16;19(1):205. doi: 10.1186/s12882-018-1004-4.

Abstract

BACKGROUND

Conservative care is argued to be a reasonable treatment alternative for dialysis in older patients with advanced chronic kidney disease (CKD). However, comparisons are scarce and generally focus on survival only. Comparative data on more patient-relevant outcomes are needed to truly foster shared decision-making on an individual level, and cost comparison is needed to assess value of care.

METHODS

We conducted a retrospective observational single-center cohort study in 366 patients aged ≥70 years with advanced CKD, who chose dialysis (n = 240) or conservative care (n = 126) after careful counselling by a multidisciplinary team in a non-academic teaching hospital in The Netherlands. Using a value-based health care approach (value = outcomes/cost): survival, health-related quality of life-cross-sectionally assessed with the Kidney Disease Quality of Life Short Form™-treatment burden, and treatment costs were evaluated.

RESULTS

The overall survival benefit of patients on a dialysis pathway compared with patients on conservative care diminished or lost significance in patients aged ≥80 years or with severe comorbidity. There were no differences between patients managed conservatively and dialysis patients on physical and mental health summary scores (all P > 0.1). Patients on conservative care had 352.7 hospital free days per year versus 282.7 in patients on a dialysis pathway, calculated from treatment decision (adjusted incidence rate ratio: 1.15, 95% confidence interval: 1.09 to 1.21, P <  0.001). Annual treatment costs were lower in patients on conservative care (adjusted cost ratio: 0.43, 95% confidence interval: 0.28 to 0.67, P <  0.001).

CONCLUSIONS

In this study, conservative care is shown to be a viable treatment option in older patients with advanced CKD, particularly in the oldest old and those with severe comorbidity. By achieving similar outcomes at lower treatment burden and treatment costs, value was generated for older patients choosing conservative care and society.

摘要

背景

对于晚期慢性肾脏病(CKD)老年患者而言,保守治疗被认为是透析治疗的一种合理替代方案。然而,相关比较研究较少,且通常仅关注生存率。需要更多与患者相关结局的比较数据,以真正促进个体层面的共同决策,同时需要进行成本比较来评估医疗价值。

方法

我们在荷兰一家非学术性教学医院进行了一项回顾性观察单中心队列研究,纳入366例年龄≥70岁的晚期CKD患者,这些患者在多学科团队仔细咨询后选择了透析治疗(n = 240)或保守治疗(n = 126)。采用基于价值的医疗保健方法(价值 = 结局/成本):评估生存率、使用肾脏疾病生活质量简表™横断面评估的健康相关生活质量 - 治疗负担以及治疗成本。

结果

与保守治疗患者相比,透析治疗患者的总体生存获益在年龄≥80岁或患有严重合并症的患者中减弱或失去显著性。保守治疗患者与透析患者在身心健康综合评分方面无差异(所有P > 0.1)。从治疗决策开始计算,保守治疗患者每年有352.7个无住院日,而透析治疗患者为282.7个(调整后的发病率比:1.15,95%置信区间:1.09至1.21,P < 0.001)。保守治疗患者的年度治疗成本较低(调整后的成本比:0.43,95%置信区间:0.28至0.67,P < 0.001)。

结论

在本研究中,保守治疗被证明是晚期CKD老年患者的一种可行治疗选择,特别是在高龄老人和患有严重合并症的患者中。通过在较低的治疗负担和治疗成本下实现相似的结局,为选择保守治疗的老年患者和社会创造了价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/997d/6097302/1294212b84c3/12882_2018_1004_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验